Multicenter Trial Comparing Surgery and Systemic Therapy in Stage IV Breast Cancer
A national multicenter trial is underway to compare 5-year overall survival between surgery followed by systemic therapy and systemic therapy alone in Stage IV breast cancer patients with solitary bone metastases.